A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Conditions
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia · Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Shannon Maude, MD)Methodist Children's Hospital, San Antonio, Texas, United States
Contact: Principal Investigator (Amanda Lipsitt, MD)Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Michael Pulsipher, MD)Hospital Vall d'Hebron, Barcelona, Spain
Contact: Principal Investigator (Cristina Diaz de Heredia, MD)Hospital Nino Jesus, Madrid, Spain
Contact: Principal Investigator (Alba Rubio, MD)Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Dr Juliana Silva, MD)Royal Manchester Children's Hospital, Manchester, United Kingdom
Contact: Principal Investigator (Denise Bonney, MD)Great North Children's Hospital, Newcastle upon Tyne, United Kingdom
Contact: Principal Investigator (Geoff Shenton, MD)